Targeted gene next-generation sequencing panel in patients with advanced lung adenocarcinoma: Paving the way for clinical implementation

Identification of targetable molecular changes is essential for selecting appropriate treatment in patients with advanced lung adenocarcinoma. Methods: In this study, a Sanger sequencing plus Fluorescence In Situ Hybridization (FISH) sequential approach was compared with a Next-Generation Sequencing...

ver descrição completa

Detalhes bibliográficos
Autor principal: Fernandes, MGO (author)
Outros Autores: Jacob, M (author), Martins, N (author), Moura, CS (author), Guimarães, S (author), Reis, J (author), Justino, A (author), Pina, MJ (author), Cirnes, L (author), Sousa, C (author), Pinto, J (author), Marques, JA (author), Machado, JC (author), Hespanhol, V (author), Costa, JL (author)
Formato: article
Idioma:eng
Publicado em: 2019
Assuntos:
Lung cancer
Molecular profiling
Next-generation sequencing
Targeted therapy
Texto completo:https://hdl.handle.net/10216/136254
País:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/136254

Texto Completo

https://hdl.handle.net/10216/136254

Registos relacionados